TIKOMED WILL BE SENDING TEAM TO BIO-EUROPE

BIO-EUROPE attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts who come together for one week of intensive networking to discover new opportunities and promising partnerships.

TikoMed will be sending representatives to take the opportunity to network and progress partner discussions for its projects. Dicussions will be focused on outlicensing of ILB, TikoMed’s neurology project but also partnering initiatives for IBsolvMIR a pharmacological product in Phase 2 intended to improve outcome for celltharapies.